First published 10/3/2026, 8:47:15 PM · Last updated 10/3/2026, 8:47:15 PM

Creation of a Pre‑biopsy Clinical Risk Score for Major Bleeding After Kidney Biopsy

Journal article describing development of a clinical risk score to predict major bleeding risk before a kidney biopsy. Source metadata indicates publication by Elsevier BV.

Illustrative image: Kidney biopsy (light microscopy): low power view of a glomerulus on a core needle biopsy in Fabry disease, × 320. Courtesy Pr Marie-Claire GUBLER, Paris, France. — Pr Marie-Claire GUBLER, Paris, France/Wikimedia Commons, CC BY 2.0

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

A pre-biopsy risk score is intended to inform assessment of bleeding risk prior to kidney biopsy.

Sources

Creation of a Pre‑biopsy Clinical Risk Score for Major Bleeding After Kidney BiopsyMetadata provided by Crossref. Usage terms

Report an issue